# A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma

> **NCT06644924** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 118 (actual)

## Conditions studied

- Asthma

## Interventions

- **COMBINATION_PRODUCT:** Intervention: AS MDI
- **COMBINATION_PRODUCT:** Intervention: Ventolin Evohaler
- **COMBINATION_PRODUCT:** Intervention: Placebo matching AS MDI

## Key facts

- **NCT ID:** NCT06644924
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-10
- **Primary completion:** 2025-06-04
- **Final completion:** 2025-06-04
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06644924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06644924, "A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06644924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*